Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China
· Delayed Price · Currency is CNY 20.92
+0.16 (0.77%)
Apr 22, 2025, 1:45 PM CST
SHA:600079 Revenue
Humanwell Healthcare (Group) had revenue of 6.28B CNY in the quarter ending September 30, 2024, with 9.66% growth. This brings the company's revenue in the last twelve months to 25.56B, up 5.63% year-over-year. In the year 2023, Humanwell Healthcare (Group) had annual revenue of 24.52B with 9.79% growth.
Revenue (ttm)
25.56B
Revenue Growth
+5.63%
P/S Ratio
1.31
Revenue / Employee
1.45M
Employees
17,676
Market Cap
33.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
| Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
| Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
| Dec 31, 2020 | 20.68B | -1.13B | -5.17% |
| Dec 31, 2019 | 21.81B | 3.17B | 17.03% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |